Knowles Corporation reports developments tied to its specialty electronic components business, including high-performance capacitors, RF and microwave filters, advanced medtech microphones, balanced armature speakers, and miniaturization products. Company updates focus on quarterly operating results, outlook, design-win activity, backlog, and demand across medtech, defense, industrial, and electrification end markets.
Recurring news also covers management conference participation and the company's continuing portfolio focus after the completed sale of its Consumer MEMS Microphone business. Knowles describes its model around custom engineering, reliable components, and scalable manufacturing for applications that require specialized electronic performance.
Knowles Corporation (NYSE: KN) has scheduled its fourth quarter and full year 2022 financial results release for February 9, 2023, after market close. A subsequent conference call will take place at 3:30 p.m. Central time (4:30 p.m. Eastern time) on the same day to discuss the results and future outlook. Investors can join the call via specific numbers provided and will have access to a webcast replay later. This financial update is crucial for stakeholders as Knowles aims to reinforce its position in advanced micro-acoustic technologies and other markets.
Knowles Corporation (NYSE: KN) has launched a new series of SiSonic MEMS microphones—Titan, Falcon, and Robin—aimed at enhancing audio experiences in wearable technology. Designed for applications like True Wireless Stereo earbuds, smartwatches, and AR/VR devices, these microphones offer high performance with low power consumption. Titan consumes 60% less current than typical digital mics and features improved latency, while Falcon boosts SNR to 68.5dB. This innovation underscores Knowles' commitment to optimizing audio clarity and battery life for consumer electronics.
Knowles Corporation (NYSE: KN) has unveiled new solutions tailored for over-the-counter (OTC) hearing aids, including three balanced armature receivers and two MEMS microphones. This release comes in light of the FDA's regulations for OTC hearing aids, effective since October 17, 2022. These components aim to enhance sound quality, design flexibility, and manufacturing efficiency. Knowles' advanced technology is positioned to support the emerging OTC market, addressing the needs of millions with mild to moderate hearing loss while ensuring high-performance standards.
Knowles Corporation (NYSE: KN) has teamed up with Trillbit Inc. to enhance IoT device setup through the integration of Trillbit’s ‘Data Over Sound’ technology with Knowles' IA61x SmartMics.
This collaboration aims to simplify device authentication and commissioning, enabling a seamless setup for consumers. By facilitating one-touch setup and secure Wi-Fi credential transfers, this integration addresses common consumer pain points, improving satisfaction and reducing product returns.
Knowles Corporation (NYSE: KN) has announced a new segment reporting structure aimed at enhancing transparency and aligning with its strategic goals. The reorganization will categorize its operations into three segments: Precision Devices, MedTech & Specialty Audio, and Consumer MEMS Microphones, effective Q4 2022. An Investor Update call is scheduled for November 29, 2022, where management will discuss the implications of this change, growth strategies, and mid-term financial targets. Knowles continues to serve diverse markets, including consumer electronics, medtech, and defense.
Knowles Corporation (NYSE: KN) will host an Investor Update call on November 29, 2022, from 9:00 a.m. Central time. CEO Jeffrey Niew and CFO John Anderson will discuss the company's segments, growth strategies, and mid-term targets announced in November 2021. The event will be accessible via webcast on the corporate website, with a Q&A session following the presentation. Additionally, Niew and Anderson will participate in a fireside chat at the Wells Fargo TMT Summit in Las Vegas on December 1, 2022, at 10:40 a.m. local time.
Knowles Corporation (NYSE: KN) reported Q3 2022 results, exceeding revenue and gross margin guidance. Revenues reached $178.2 million, with a gross profit of $40.0 million (22.4% margin). Diluted EPS was $0.03, up from a loss of $2.64 in Q2 2022. The Precision Devices segment experienced strong growth in defense, medtech, and EV markets. The company initiated $19 million in share repurchases and anticipates sequential revenue growth in Q4 across key segments. Cost restructuring is expected to yield $25-30 million in annual savings starting in 2023.
Knowles Corporation (NYSE: KN) has announced the release date for its third quarter 2022 financial results, scheduled for October 27, 2022, after market close. Following the results, the company will hold a conference call to discuss the financial performance and outlook at 3:30 p.m. Central time (4:30 p.m. Eastern time). Analysts and investors can join the call using a specific conference number and ID. A replay will be available post-call, along with a webcast accessible on Knowles' investor website.
Knowles Corporation (NYSE: KN) has launched KN2, the first True Wireless Stereo reference design optimized for high-definition audio, incorporating the Knowles Preferred Listening Response Curve. KN2 features a hybrid dual speaker system, advanced Bluetooth SoC, and active noise cancellation, aiming to elevate consumer audio experiences. This launch addresses increasing demand for premium sound in the TWS market. The KN2 will be available on Digi-Key and Mouser in Q4 2022, highlighting Knowles' commitment to innovation based on over 75 years of audio expertise.
Knowles Corporation (NYSE: KN) reported Q2 results with revenues of $188 million, a 5.8% decrease year-over-year despite a 19% growth in Precision Devices and Hearing Health segments. The gross margin was 41.3%, while non-GAAP gross margin reached 41.5%. CEO Jeffrey Niew highlighted a restructuring program aiming for $25-$30 million in annual savings, focusing on high-margin products. However, the company incurred a diluted loss per share of $(2.64) due to significant goodwill impairment charges totaling $239.8 million.